首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1701028

精準醫療市場規模、佔有率、成長分析、按技術、按產品、按定序技術、按給藥途徑、按應用、按最終用途、按地區 - 2025 年至 2032 年行業預測

Precision Medicine Market Size, Share, and Growth Analysis, By Technology, By Product, By Sequencing Technology, By Route of Administration, By Application, By End-Use, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月04日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

精準醫療市場規模預計在 2023 年達到 823 億美元，並將從 2024 年的 955.5 億美元成長到 2032 年的 3154.2 億美元，預測期內（2025-2032 年）的複合年成長率為 16.1%。

精準醫療正在徹底改變醫療保健，因為它認知到人體對同一種疾病的反應會因遺傳和環境影響等因素而有所不同。這種方法使醫療專業人員能夠根據患者的獨特症狀和基因組成客製化治療方案，從而有可能改善治療效果並降低整體護理成本。隨著這一領域的擴大，人們越來越關注基因組學研究和基因標靶治療方法的開發。此外，涉及基因檢測的伴隨診斷的普及度也在上升，進一步推動了市場的成長。這一快速成長的領域受到專科藥物監管核准日益增多的大力支持，使精準醫療成為現代醫療保健策略的重要組成部分。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）
  主要企業簡介
  - 霍夫曼-羅氏有限公司（瑞士）
  - 諾華公司（瑞士）
  - 輝瑞公司（美國）
  - 百時美施貴寶（美國）
  - 阿斯特捷利康（英國）
  - Almac Group Ltd.（英國）
  - 吉利德科學公司（美國）
  - 艾伯維公司（美國）
  - 禮來公司（美國）
  - 葛蘭素史克公司（英國）
  - Ab-BIoTics Sa（美國）
  - 強生公司（美國）
  - 默克集團（德國）
  - 安進公司（美國）

結論和建議

簡介目錄

Product Code: SQMIG35B2061

Precision Medicine Market size was valued at USD 82.3 billion in 2023 and is poised to grow from USD 95.55 billion in 2024 to USD 315.42 billion by 2032, growing at a CAGR of 16.1% during the forecast period (2025-2032).

Precision medicine is revolutionizing healthcare by recognizing that individuals with the same illness can have varied physical responses due to factors like genetics and environmental influences. This approach allows healthcare professionals to tailor treatments based on a patient's unique symptoms and genetic makeup, improving therapeutic effectiveness while potentially lowering overall treatment costs. As the field expands, there is an increasing focus on genomics research and the development of genetically targeted therapies. Additionally, the popularity of companion diagnostics that involve genetic testing is on the rise, further propelling market growth. This burgeoning sector is significantly supported by an increase in specialized drug approvals from regulatory bodies, positioning precision medicine as a vital component of modern healthcare strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Precision Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Precision Medicine Market Segments Analysis

Global Precision Medicine Market is segmented by Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use and region. Based on Technology, the market is segmented into Bioinformatics, Big Data Analytics, Drug Discovery, Gene Sequencing, Companion Diagnostics and Others. Based on Product, the market is segmented into Consumables, Instruments and Services. Based on Sequencing Technology, the market is segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing and Nanopore Sequencing. Based on Route of Administration, the market is segmented into Oral, Injectable, By Drugs, Alectinib, Osimertinib, Mepolizumab, Aripiprazole Lauroxil and Others. Based on Application, the market is segmented into CNS, Immunology, Oncology, Respiratory and Others. Based on End-Use, the market is segmented into Diagnostic Companies, Pharmaceutical Companies, Healthcare IT companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Precision Medicine Market

The Precision Medicine market is primarily driven by the comprehensive diagnostic assessments that analyze a patient's genetic makeup for variations, mutations, and individual differences. This tailored approach to treatment is increasingly supported by the growing accessibility of prenatal and cancer screening tests, as well as direct-to-consumer genetic tests. These developments are stimulating the demand for genetic testing services, which enables healthcare providers to create personalized treatment plans based on specific genetic information. Consequently, the market for Precision Medicine continues to expand as more patients seek customized healthcare solutions that address their unique genetic profiles.

Restraints in the Precision Medicine Market

The Precision Medicine market faces notable restraints due to significant privacy and security issues associated with the extensive collection and analysis of personal genetic and health data. The handling of such sensitive information raises the risk of breaches and other forms of misuse, which can jeopardize patient trust and confidence in these medical advancements. As concerns mount over the protection of individual data, the adoption of precision medicine solutions may be hindered, resulting in increased skepticism among potential patients and healthcare providers alike. Addressing these privacy challenges is crucial for fostering a more favorable environment for the growth of the Precision Medicine market.

Market Trends of the Precision Medicine Market

The precision medicine market is experiencing a transformative shift, driven by the integration of genetic insights and targeted therapies into healthcare frameworks. Advances in DNA sequencing and molecular profiling are pivotal, enabling clinicians to craft personalized treatment regimens tailored to an individual's unique genetic makeup. This trend not only enhances diagnostic accuracy but also optimizes treatment efficacy, resulting in improved patient outcomes. As healthcare shifts from a one-size-fits-all model to a more individualized approach, the demand for precision medicine continues to grow, highlighting its crucial role in the evolution of contemporary medicine and paving the way for innovative health solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Precision Medicine Market Size by Technology & CAGR (2025-2032)

Market Overview
Bioinformatics
Big Data Analytics
Drug Discovery
Gene Sequencing
Companion Diagnostics
Others

Global Precision Medicine Market Size by Product & CAGR (2025-2032)

Market Overview
Consumables
Instruments
Services

Global Precision Medicine Market Size by Sequencing Technology & CAGR (2025-2032)

Market Overview
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real Time Sequencing
Chain Termination Sequencing
Nanopore Sequencing

Global Precision Medicine Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Oral
Injectable
By Drugs
Alectinib
Osimertinib
Mepolizumab
Aripiprazole Lauroxil
Others

Global Precision Medicine Market Size by Application & CAGR (2025-2032)

Market Overview
CNS
Immunology
Oncology
Respiratory
Others

Global Precision Medicine Market Size by End-Use & CAGR (2025-2032)

Market Overview
Diagnostic Companies
Pharmaceutical Companies
Healthcare IT companies
Others

Global Precision Medicine Market Size & CAGR (2025-2032)

North America (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- US
- Canada
Europe (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ab-Biotics Sa (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments